# Mitoxantrone

NDC: 63323-132
Generic name: MITOXANTRONE HYDROCHLORIDE
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20060411

FDA application: ANDA077496

## Active ingredients

- MITOXANTRONE HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-132"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-132
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcb8ef8a-f770-4416-8fc5-fa01d98c8eee